Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's AbbVie Inc Holding Summary
As of 2023-09-30, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund held 3,152.00 shares of AbbVie Inc(ABBV), totaling $469,840.00. This investment constitutes 3.08% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2019Q3. And since then Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund has made 5 purchases of ABBV, at an average price of $118.96, for a total of 5,022.00 shares. In addition, there have been 3 sales at an average price of $85.78 for 1,870.00 shares. Based on historical transaction data and ABBV's current price of $185.39, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's estimated gain on his ABBV holdings is $147,344.31, reflecting a 24.66% gain to date.
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund ABBV ($185.39) Holding Chart
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund ABBV ($185.39) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
